Aptuit recognizes that the pharmaceutical industry is experiencing increasingly stringent regulations, due to factors like the public outcry and the subsequent restrictions on the market price of drugs, the increasing call for “green chemistry," mounting safety requirements, the constant threat of patient litigation, the complexities of chemistries, the move to more active/potent compounds, and lower volumes of API required. At the same time, the market is expanding globally, creating more competitive pressures. Both factors are converging to create the demand for high-quality active pharmaceutical ingredients (APIs) and the need to outsource to top providers.

Aptuit offers a broad range of services that allow you to establish and maintain tight control over your API. We focus on process through a production continuum, gram through kilo to tens of kilos in scale.

Our approach is:

Prospective – we anticipate problems early in the API development process.

Proactive – we help you establish structures and protocols to avoid those potential problems.

Systemic – we can manage any particular component of your process development, or we can streamline management of the many pieces into a route of synthesis that is:

• Efficient
• Reproducible
• Safe
• Economical
• Environmentally-friendly

All materials we supply for clinical trials are manufactured in strict compliance with Good Manufacturing Practices (cGMP) and meet the highest standards of quality, safety, and consistency.

Any improvements to a client’s Intellectual Property belong to that client. Clients can also be assured that all work is performed under confidentiality.